Nvsk Rao

Title: Innovations by Nvsk Rao in the Field of Pharmaceutical Compounds

Introduction

Nvsk Rao is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of PAD inhibitors. His work is crucial for advancing treatments for various disorders.

Latest Patents

Nvsk Rao holds a patent for "Imidazo-pyridine compounds as PAD inhibitors." This patent describes heterocyclic compounds of Formula (I), (II), and (III), along with their polymorphs, stereoisomers, prodrugs, solvates, co-crystals, intermediates, pharmaceutically acceptable salts, and metabolites. The compounds are identified as PAD4 inhibitors and may be beneficial in treating conditions such as rheumatoid arthritis, vasculitis, systemic lupus erythematosus, cutaneous lupus erythematosus, ulcerative colitis, cancer, cystic fibrosis, asthma, multiple sclerosis, and psoriasis. The patent also outlines the preparation process for these compounds and their pharmaceutical compositions.

Career Highlights

Nvsk Rao is currently associated with Jubilant Epipad LLC, where he continues to innovate in the pharmaceutical sector. His expertise in developing novel compounds has positioned him as a valuable asset in his field.

Collaborations

He has collaborated with notable colleagues, including Gurulingappa Hallur and Athisayamani Jeyaraj Duraiswamy, to further enhance the research and development of pharmaceutical solutions.

Conclusion

Nvsk Rao's contributions to the field of pharmaceutical compounds, particularly through his patent on PAD inhibitors, highlight his role as an influential inventor. His work has the potential to significantly impact the treatment of various medical conditions.